Find the latest Mineralys Therapeutics, Inc. (MLYS) stock quote, history, news and other vital information to help you with your stock trading and investing.

Mar 18, 2025 · MLYS | Complete Mineralys Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Get the latest Mineralys Therapeutics Inc (MLYS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Mar 11, 2025 · Mineralys Therapeutics, Inc. (the “Company”) is a clinical-stage biopharmaceutical company committed to developing treatments for diseases that are driven by abnormally elevated aldosterone.

12 hours ago · We recently published a list of Insiders Are Spending Big: 15 Stocks Leading in March. In this article, we are going to take a look at where Mineralys Therapeutics, Inc. (NASDAQ:MLYS) stands ...

Mar 10, 2025 · Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, CKD, OSA and other diseases driven by dysregulated aldosterone.

Mar 18, 2025 · See the latest Mineralys Therapeutics Inc stock price (MLYS:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

5 days ago · Should You Buy or Sell Mineralys Therapeutics Stock? Get The Latest MLYS Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.

We are focused on improving outcomes for people managing hypertension, CKD and related diseases that are driven by dysregulated aldosterone. Positive Topline Results from Launch …

6 days ago · View Mineralys Therapeutics, Inc MLYS investment & stock information. Get the latest Mineralys Therapeutics, Inc MLYS detailed stock quotes, stock data, Real-Time ECN, charts, stats and...